
Episode # 525 • 25 May 2026
Multi-Cancer Early Detection Testing
Cut through the hype of Multi-Cancer Early Detection (MCED) tests and learn how to counsel patients on the real-world utility, false-positive risks, and the “stage shift” debate of these emerging blood assays. We are joined by world-renowned oncologist Dr. Margaret Tempero, UCSF Cancer Early Detection and Interception, to discuss whether these tests are truly ready for clinical prime time.
Claim CME for this episode at curbsiders.vcuhealth.org!
Resources
You may also like
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.